Can Fite Biopharma Ltd

Can Fite Biopharma Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.23
  • Today's Change-0.070 / -3.04%
  • Shares traded207.00
  • 1 Year change-81.42%
  • Beta--
Data delayed at least 15 minutes, as of Mar 29 2023 15:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Institutional shareholders

1.15%Per cent of shares held by top holders
HolderShares% Held
Morgan Stanley & Co. LLCas of 31 Dec 202230.47k0.82%
G1 Execution Services LLCas of 31 Dec 20223.27k0.09%
Fifth Third Bank, NA (Investment Management)as of 31 Dec 20223.00k0.08%
Two Sigma Securities LLCas of 31 Dec 20222.70k0.07%
Stifel Nicolaus & Co., Inc. (Investment Management)as of 31 Dec 20221.20k0.03%
UBS Securities LLCas of 31 Dec 2022871.000.02%
National Bank Financial, Inc.as of 31 Dec 2022600.000.02%
Citigroup Global Markets, Inc. (Investment Management)as of 31 Dec 2022554.000.02%
BNP Paribas Arbitrage SNCas of 31 Dec 202240.000.00%
American Portfolios Advisors, Inc.as of 31 Dec 20220.000.00%
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.